In a report released yesterday, David Larsen from BTIG maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...
Tactile Systems (TCMD) stock was downgraded by BTIG to neutral as its Q3 revenue misses expectations. Read more here.
BTIG Research has recently initiated Capital One Financial Corp. (COF) stock to Neutral rating, as announced on June 7, 2024, according to Finviz. Earlier, on June 6, 2024, Jefferies had raised the ...
BTIG analyst Ryan Zimmerman maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) yesterday and set a price target of $99.00. The company’s shares closed yesterday at ...
Nvidia, which importantly commands an S&P 500 weighting of around 7%, touched an intraday high near $144.50 on Tuesday. That breakout to a fresh record was closely-watched says Jonathan Krinsky, chief ...
BTIG Research upgraded shares of Wingstop (NASDAQ:WING – Free Report) from a neutral rating to a buy rating in a research ...
Investing.com -- BTIG upgraded Wingstop (NASDAQ:WING) to Buy with a price target of $370 on Thursday, citing opportunities for long-term growth despite recent concerns around the company's fourth ...
The October 22 report on Hoka noted signs that the running footwear brand’s multi-year growth is moderating. The firm also ...
BTIG upgraded Wingstop (WING) to Buy from Neutral with a $370 price target The analyst cites the post-earnings selloff in the shares for the upgrade. The decline below $300 represents an ...
The S&P 500 was rising 0.3% on Tuesday afternoon, on pace for the 28th consecutive trading day where the large-cap benchmark index moved less than 1% in either direction, according to FactSet data.
BTIG raised the firm’s price target on Castle Biosciences (CSTL) to $45 from $40 and keeps a Buy rating on the shares. The company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback